HUTCHMED (China) Ltd (NAS:HCM)
$ 17.37 0.01 (0.06%) Market Cap: 3.04 Bil Enterprise Value: 2.33 Bil PE Ratio: 0 PB Ratio: 4.12 GF Score: 68/100

Hutchison China MediTech Ltd at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 01:55PM GMT
Release Date Price: $21.96 (+1.10%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. So good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Just quickly before we get started, I need to read an important disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures or you can pick up your own copy at the registration desk. So, Christian, pleased to have you here. Christian, CEO of Chi-Med. I thought, just quickly to get us started, there's been a wave of new biotech companies in China. You've obviously as a company had a long history in China. So maybe -- for the audience, maybe just describe to us what you see as your advantages given your history of operating in that market.

Christian Hogg
Hutchison China MediTech Limited - CEO & Executive Director

Great. Thanks, Matt. So Hutchison China MediTech or Chi

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot